Roquette plans to open doors of new US innovation center

Join us tomorrow, January 19th at 10:00 a.m. EST, to hear from Harry Moser, founder of the Reshoring Initiative, an… https://t.co/6EMq7hyHOs

January, 18
Reshoring of jobs from overseas could create 200,000 positions this year. Can the US cash in on these growing… https://t.co/Q537Oizy1c

January, 17
While the US may design chips based on customer requirements, most equipment is being manufactured abroad. As suppl… https://t.co/6yvcNgAC1o

January, 14

URL	HTTPS://WWW.OUTSOURCING-PHARMA.COM/ARTICLE/2021/12
Source	Outsourcing Pharma
Date Published	12/08/2021
Author Name	Jenni Spinner
Mentions specific company case(s) of reshoring, kept from offshoring, or transplant	Yes

Company/Division name	Roquette Pharma Solutions
Parent company	Roquette Pharma Solutions
Type of work	Manufacturing
Reshoring category:	Foreign Direct Investment
Country(ies) from which reshored:	France
City reshored to:	Spring House
State(s) reshored to:	PA
If relevant, work nearshored to:	-
Industry(ies):	Medical Equipment & Supplies
Product(s) reshored	drug delivery systems
What domestic positive factors made reshoring more attractive?	Customization/Flexibility, Eco-system synergies, Lead time/Time to market, Lean/other business process improvement techniques, Manufacturing/engineering joint innovation (R&D), Proximity to customers/market

Library